Cash & equivalents increased 215.6%
Cash & equivalents changed +215.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +215.6% from the comparable as-filed period.
Net income changed +31.0% from the comparable as-filed period.
Operating income changed +14.5% from the comparable as-filed period.
Operating margin changed +60 basis points from the comparable as-filed period.
Revenue changed +8.4% from the comparable as-filed period.
Inventory / revenue changed -156 basis points from the comparable as-filed period.
Selling, general & administrative changed +11.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -3.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
SBC / revenue changed -6 basis points from the comparable as-filed period.
Inventory changed +1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.